{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:49:39Z","timestamp":1791838179141,"version":"4.3.4"},"reference-count":55,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA284315"],"award-info":[{"award-number":["R01 CA284315"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016302","name":"Coalition for Epidemic Preparedness Innovations","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016302","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R35GM138184"],"award-info":[{"award-number":["R35GM138184"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI195888"],"award-info":[{"award-number":["R01AI195888"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RR220017"],"award-info":[{"award-number":["RR220017"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["K22 NS112678"],"award-info":[{"award-number":["K22 NS112678"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012615","name":"University of Texas Health Science Center at Houston","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012615","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00347894"],"award-info":[{"award-number":["RS-2024-00347894"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2022-NR070196"],"award-info":[{"award-number":["RS-2022-NR070196"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.isci.2026.116076","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T18:01:07Z","timestamp":1780164067000},"page":"116076","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["FusionTarget: Computational framework for drug repurposing against modeled fusion protein structures from genomic breakpoints"],"prefix":"10.1016","volume":"29","author":[{"given":"Himansu","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan V.","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-Sook","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Hsing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juyoung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalaka R.","family":"Lotlikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Young","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Toh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon-La","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristopher W.","family":"Brannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8321-6864","authenticated-orcid":false,"given":"Pora","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.116076_bib1","doi-asserted-by":"crossref","first-page":"D1289","DOI":"10.1093\/nar\/gkad920","article-title":"FusionPDB: a knowledgebase of human fusion proteins","volume":"52","author":"Kumar","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2026.116076_bib2","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1038\/s41467-025-56745-6","article-title":"FusOn-pLM: a fusion oncoprotein-specific language model via adjusted rate masking","volume":"16","author":"Vincoff","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.116076_bib3","doi-asserted-by":"crossref","first-page":"RP95626","DOI":"10.7554\/eLife.95626.4","article-title":"The DBD-\u03b14 helix of EWSR1::FLI1 is required for GGAA microsatellite binding that underlies genome regulation in Ewing sarcoma","volume":"13","author":"Bayanjargal","year":"2024","journal-title":"eLife"},{"key":"10.1016\/j.isci.2026.116076_bib4","doi-asserted-by":"crossref","first-page":"5093","DOI":"10.2147\/OTT.S193363","article-title":"Management of Refractory Pediatric Sarcoma: Current Challenges and Future Prospects","volume":"13","author":"Pushpam","year":"2020","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.isci.2026.116076_bib5","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/CCO.0000000000001048","article-title":"Emerging therapies in Ewing sarcoma","volume":"36","author":"Strauss","year":"2024","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.isci.2026.116076_bib6","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1182\/blood.V81.9.2386.2386","article-title":"Molecular rearrangements on chromosome 11q23 predominate in infant acute lymphoblastic leukemia and are associated with specific biologic variables and poor outcome","volume":"81","author":"Chen","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.isci.2026.116076_bib7","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/sj.leu.2401413","article-title":"Cytogenetic studies of infant acute lymphoblastic leukemia: poor prognosis of infants with t(4;11) \u2013 a report of the Children\u2019s Cancer Group","volume":"13","author":"Heerema","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.isci.2026.116076_bib8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev-pathol-011811-132434","article-title":"The pathogenesis of mixed-lineage leukemia","volume":"7","author":"Muntean","year":"2012","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.isci.2026.116076_bib9","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-021-01057-7","article-title":"Structure, function and inhibition of critical protein\u2013protein interactions involving mixed lineage leukemia 1 and its fusion oncoproteins","volume":"14","author":"Li","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.isci.2026.116076_bib10","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/s41375-023-01877-1","article-title":"The KMT2A recombinome of acute leukemias in 2023","volume":"37","author":"Meyer","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.isci.2026.116076_bib11","doi-asserted-by":"crossref","first-page":"E334","DOI":"10.1002\/ajh.26253","article-title":"Prognostic impact of KMT2A-AFF1-positivity in 926 BCR-ABL1-negative B-lineage acute lymphoblastic leukemia patients treated in GIMEMA clinical trials since 1996","volume":"96","author":"Piciocchi","year":"2021","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.isci.2026.116076_bib12","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/s41586-023-05812-3","article-title":"The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia","volume":"615","author":"Issa","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.116076_bib13","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.cell.2017.07.036","article-title":"Cancer-Specific Retargeting of BAF Complexes by a Prion-like Domain","volume":"171","author":"Boulay","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.isci.2026.116076_bib14","doi-asserted-by":"crossref","first-page":"D1221","DOI":"10.1093\/nar\/gkab1056","article-title":"FusionGDB 2.0: fusion gene annotation updates aided by deep learning","volume":"50","author":"Kim","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2026.116076_bib15","doi-asserted-by":"crossref","first-page":"D941","DOI":"10.1093\/nar\/gky1015","article-title":"COSMIC: The catalogue of somatic mutations in cancer","volume":"47","author":"Tate","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2026.116076_bib16","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"Barretina","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.116076_bib17","doi-asserted-by":"crossref","first-page":"D994","DOI":"10.1093\/nar\/gky1067","article-title":"FusionGDB: fusion gene annotation DataBase","volume":"47","author":"Kim","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2026.116076_bib18","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.116076_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1789","article-title":"Artificial intelligence in fusion protein three-dimensional structure prediction: Review and perspective","volume":"14","author":"Kumar","year":"2024","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.isci.2026.116076_bib20","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1021\/ci800324m","article-title":"Identifying and characterizing binding sites and assessing druggability","volume":"49","author":"Halgren","year":"2009","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.isci.2026.116076_bib21","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1107\/S0907444909042073","article-title":"MolProbity: all-atom structure validation for macromolecular crystallography","volume":"66","author":"Chen","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.isci.2026.116076_bib22","doi-asserted-by":"crossref","first-page":"D1265","DOI":"10.1093\/nar\/gkad976","article-title":"DrugBank 6.0: the DrugBank Knowledgebase for 2024","volume":"52","author":"Knox","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2026.116076_bib23","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.116076_bib24","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.molcel.2010.01.026","article-title":"AFF4, a component of the ELL\/P-TEFb elongation complex and a shared subunit of MLL chimeras, can link transcription elongation to leukemia","volume":"37","author":"Lin","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.isci.2026.116076_bib25","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/106002809703100112","article-title":"Nilutamide: An antiandrogen for the treatment of prostate cancer","volume":"31","author":"Dole","year":"1997","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.isci.2026.116076_bib26","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11864-018-0519-z","article-title":"Androgen therapy for acute myeloid and hairy cell leukemia","volume":"19","author":"Wiernik","year":"2018","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1016\/j.isci.2026.116076_bib27","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1586\/14737140.7.11.1517","article-title":"Samarium lexidronam (153Sm-EDTMP): skeletal radiation for osteoblastic bone metastases and osteosarcoma","volume":"7","author":"Anderson","year":"2007","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.isci.2026.116076_bib28","first-page":"6154709","article-title":"Solitary lytic bone metastasis: A rare presentation of small Lymphocytic leukemia","volume":"2018","author":"Katz","year":"2018","journal-title":"Case Rep. Hematol."},{"key":"10.1016\/j.isci.2026.116076_bib29","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-225008","article-title":"Acute lymphoblastic leukaemia with osteolytic bone lesions: diagnostic dilemma","volume":"2018","author":"Angsubhakorn","year":"2018","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.isci.2026.116076_bib30","article-title":"Extensive bone marrow necrosis and osteolytic lesions in a case of acute myeloid leukemia transformed from polycythemia Vera","volume":"8","author":"Chambers","year":"2016","journal-title":"Cureus"},{"key":"10.1016\/j.isci.2026.116076_bib31","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ijpharm.2015.04.027","article-title":"Broad spectrum UV protection by crystalline organic microrod sunscreens","volume":"489","author":"Gause","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.isci.2026.116076_bib32","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/1756287214541798","article-title":"Use of intravesical valrubicin in clinical practice for treatment of nonmuscle-invasive bladder cancer, including carcinoma in situ of the bladder","volume":"6","author":"Cookson","year":"2014","journal-title":"Ther. Adv. Urol."},{"key":"10.1016\/j.isci.2026.116076_bib33","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/hon.3164_373","article-title":"Brigatinib in patients with ALK-positive anaplastic large cell lymphoma who have failed brentuximab vedotin","volume":"41","author":"Veleanu","year":"2023","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.isci.2026.116076_bib34","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1042\/CS20150149","article-title":"Cellular and molecular effects of the mTOR inhibitor everolimus","volume":"129","author":"Saran","year":"2015","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.isci.2026.116076_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242216346","article-title":"PROTAC-Based Protein Degradation as a Promising Strategy for Targeted Therapy in Sarcomas","volume":"24","author":"Mancarella","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.116076_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17040501","article-title":"PROTAC Delivery Strategies for Overcoming Physicochemical Properties and Physiological Barriers in Targeted Protein Degradation","volume":"17","author":"Syahputra","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.isci.2026.116076_bib37","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1002\/1878-0261.13081","article-title":"EWS-FLI1-targeting peptide identifies Ewing sarcoma tumor boundaries and lymph node metastasis via near-infrared imaging","volume":"15","author":"Wang","year":"2021","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.isci.2026.116076_bib38","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41392-024-02107-5","article-title":"Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines","volume":"10","author":"Xiao","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.isci.2026.116076_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13153783","article-title":"Therapeutic Potential of EWSR1-FLI1 Inactivation by CRISPR\/Cas9 in Ewing Sarcoma","volume":"13","author":"Cervera","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.isci.2026.116076_bib40","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.7150\/ijms.112724","article-title":"Overcoming the Delivery Challenges in CRISPR\/Cas9 Gene Editing for Effective Cancer Treatment: A Review of Delivery Systems","volume":"22","author":"Tang","year":"2025","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.isci.2026.116076_bib41","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.3324\/haematol.2017.164046","article-title":"CRISPR-Cas9-induced t(11;19)\/MLL-ENL translocations initiate leukemia in human hematopoietic progenitor cells in vivo","volume":"102","author":"Reimer","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.isci.2026.116076_bib43","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41592-023-02130-4","article-title":"Improving deep learning protein monomer and complex structure prediction using DeepMSA2 with huge metagenomics data","volume":"21","author":"Zheng","year":"2024","journal-title":"Nat. Methods"},{"key":"10.1016\/j.isci.2026.116076_bib44","doi-asserted-by":"crossref","DOI":"10.1126\/science.ads9530","article-title":"Deep contrastive learning enables genome-wide virtual screening","volume":"391","author":"Jia","year":"2026","journal-title":"Science"},{"key":"10.1016\/j.isci.2026.116076_bib45","series-title":"ICML 2025 Workshop on Scaling up Intervention Models","article-title":"SOAPIA : Siamese-Guided Generation of Off Target-Avoiding Protein Interactions with High Target Affinity","author":"Sophia","year":"2025"},{"key":"10.1016\/j.isci.2026.116076_bib48","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","article-title":"Next-generation characterization of the Cancer Cell Line Encyclopedia","volume":"569","author":"Ghandi","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.116076_bib49","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.3390\/biom12101425","article-title":"Protein Data Bank: A Comprehensive Review of 3D Structure Holdings and Worldwide Utilization by Researchers, Educators, and Students","volume":"12","author":"Burley","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.isci.2026.116076_bib51","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1021\/acs.jcim.2c01253","article-title":"ZINC-22\u2500A Free Multi-Billion-Scale Database of Tangible Compounds for Ligand Discovery","volume":"63","author":"Tingle","year":"2023","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.isci.2026.116076_bib50","doi-asserted-by":"crossref","first-page":"D56","DOI":"10.1093\/nar\/gkae1114","article-title":"GenBank 2025 update","volume":"53","author":"Sayers","year":"2025","journal-title":"Nucleic. Acids Res."},{"key":"10.1016\/j.isci.2026.116076_bib52","doi-asserted-by":"crossref","first-page":"W431","DOI":"10.1093\/nar\/gkab314","article-title":"Mol\u2217 Viewer: modern web app for 3D visualization and analysis of large biomolecular structures","volume":"49","author":"Sehnal","year":"2021","journal-title":"Nucleic. Acids Res."},{"key":"10.1016\/j.isci.2026.116076_bib53","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera--a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.isci.2026.116076_bib54","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1093\/bioinformatics\/btm404","article-title":"Clustal W and Clustal X version 2.0","volume":"23","author":"Larkin","year":"2007","journal-title":"Bioinformatics"},{"key":"10.1016\/j.isci.2026.116076_bib55","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1021\/ci800324m","article-title":"Identifying and characterizing binding sites and assessing druggability","volume":"49","author":"Halgren","year":"2009","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.isci.2026.116076_bib56","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.isci.2026.116076_bib46","doi-asserted-by":"crossref","first-page":"D29","DOI":"10.1093\/nar\/gkac1032","article-title":"Database resources of the National Center for Biotechnology Information in 2023","volume":"51","author":"Sayers","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2026.116076_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16234017","article-title":"Synergistic Strategies for KMT2A-Rearranged Leukemias: Beyond Menin Inhibitor","volume":"16","author":"Cantilena","year":"2024","journal-title":"Cancers (Basel)"}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226014513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226014513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:36:10Z","timestamp":1791837370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226014513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2589004226014513"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.116076","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FusionTarget: Computational framework for drug repurposing against modeled fusion protein structures from genomic breakpoints","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.116076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116076"}}